Donepezil Market Insights, Forecast to 2026 Published on : 19 June 2020
Report Overview The following manufacturers are covered in this report. • • • • • • • • • • •
Eisai Pfizer Teva Sandoz Apotex Dr Reddy's Laboratories Sun Pharmaceutical Hansoh Pharma Cipla ARK PHA.LTD Jishengtang Pharma
Report Overview Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease. Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping. The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Donepezil 3900 market in 2020.
Market Size Download Free Sample
2020
Forecast year
Expected to reach $xx million USD by the end of
2026
Base year
CAGR xx% (2020 - 2026) +91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
By Region United States
Europe
China
Rest of the world Japan
+91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
Application • Hospitals • Clinics • Drugstore
+91-8087042414 (Asia) | (+1) 646 781 7170 (Int'l) | help@grandresearchstore.com
Get in touch Call: +91-8087042414 (Asia) (+1) 646 781 7170 (Int'l)
Download Free Sample Sample includes
Table Of Contents
List of Tables & Figures
E-mail:
Charts
help@grandresearchstore.com
Research Methodology